TAK · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $52.3B · 47,455 employees
331
SEC Filings
$15.84
Close 2026-06-23
47,455
Employees
Business Summary
Takeda Pharmaceutical Co Ltd is a global biopharmaceutical company focused on discovering, developing, and commercializing pharmaceutical products. Its portfolio includes treatments across gastroenterology, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Key products include ENTYVIO, VYVANSE, and TAK-003 (dengue vaccine). The company operates research and development programs both in-house and through third-party collaborations, with products marketed across multiple international markets.
Latest Stock Quote
TAK 2026-06-23 $15.84
O:$15.65 H:$15.85 L:$15.5 Vol:3.1M VWAP:$15.788
origin leaf: null
331 total filings indexed. 331 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Look up TAK using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on TAK, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/TAK (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.